Jefferies Upgrades Kindred Healthcare (KND) to Buy

Jefferies upgraded Kindred Healthcare (NYSE: KND) from Hold to Buy with a price target of $13 (up from $11).

The firm comments, "We are upgrading KND to Buy (from Hold) and raising our PT to $13 (from $11) after CMS issued a better-than-expected FY13 proposed LTCH rule. We believe improved reimbursement visibility will allay investor anxieties and push this highly discounted stock higher."

FY12 EPS goes from $1.50 to $1.45.

For an analyst ratings summary and ratings history on Kindred Healthcare click here. For more ratings news on Kindred Healthcare click here.

Shares of Kindred Healthcare closed at $8.30 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
• Samsonite International SA (1910:HK) (SMSEY) PT Lowered to HK$19.60 at Macquarie
• Rakus Co Ltd (3923:JP) PT Raised to JPY1,300 at Macquarie